Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,363 | 194,905 | 4,762 | 59,640 | 55,570 |
| Marketable Securities | 1,228,499 | 1,140,445 | 291,370 | 329,462 | 253,374 |
| Receivables | 36,802 | 43,213 | 5,014 | 15,678 | 19,947 |
| Inventories | 12,665 | 11,381 | 10,726 | 11,109 | 11,346 |
| Other current assets | 47,221 | 47,743 | 14,948 | 10,063 | 9,814 |
| TOTAL | $1,421,550 | $1,437,687 | $326,820 | $425,952 | $350,051 |
| Non-Current Assets | |||||
| PPE Net | 65,665 | 48,851 | 47,463 | 65,601 | 71,336 |
| Investments And Advances | 279,119 | 582,889 | 57,088 | 0 | 0 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 134,521 | 4,244 | 994 | 817 | 754 |
| TOTAL | $555,806 | $712,485 | $182,046 | $142,919 | $148,591 |
| Total Assets | $1,977,356 | $2,150,172 | $508,866 | $568,871 | $498,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 252,891 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 19,234 | 5,854 | 4,782 | 2,816 | 2,363 |
| Accrued Expenses | 51,397 | 52,676 | 25,767 | 30,436 | 18,416 |
| Other current liabilities | N/A | 493 | 446 | 19,907 | 10,127 |
| TOTAL | $353,893 | $82,002 | $56,163 | $72,222 | $61,246 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 246,950 | 245,207 | 243,464 | 241,699 |
| Deferred Revenues | 5,517 | 13,892 | 18,949 | 14,352 | 21,428 |
| Other Non-Current Liabilities | 215,518 | 92,901 | 100,647 | 113,173 | 125,769 |
| TOTAL | $218,072 | $350,595 | $364,875 | $408,524 | $430,967 |
| Total Liabilities | $571,965 | $432,597 | $421,038 | $480,746 | $492,213 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,843 | 11,613 | 10,734 | 10,261 | 9,067 |
| Common Shares | 17 | 17 | 15 | 15 | 13 |
| Retained earnings | -1,864,718 | -1,424,051 | -2,117,941 | -2,021,010 | -1,867,486 |
| Other shareholders' equity | -1,005 | -6,316 | -2,111 | -2,363 | -2,170 |
| TOTAL | $1,405,391 | $1,717,575 | $87,828 | $88,125 | $6,429 |
| Total Liabilities And Equity | $1,977,356 | $2,150,172 | $508,866 | $568,871 | $498,642 |